Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-12-13, Stock:JNJ, The news for the past five days is as follows:
2018-12-06: NEWS1: Johnson & Johnson (JNJ) Stock Moves -0.08%: What You Should Know.NEWS2: J&J unit to pay $360 million to U.S. to resolve charity kickback probe.NEWS3: Peninsula drug maker to pay $360M to settle Justice Department claims.NEWS4: Can You Hide in Johnson and Johnson Stock Amid the Turmoil?.NEWS5: Can You Hide in Johnson and Johnson Stock Amid the Turmoil?.NEWS6: 7 Dividend Titans Trading Like Growth Stocks.NEWS7: Houston cancer pharma co. begins Phase I trials after $6M Series B.NEWS8: AbbVie Halts Rova-T Phase III Second-Line Lung Cancer Study.NEWS9: AbbVie Halts Rova-T Phase III Second-Line Lung Cancer Study.NEWS10: Drug company Actelion to pay $360M in kickback probe.NEWS11: Noteworthy ETF Inflows: IWD, JPM, XOM, JNJ.NEWS12: Noteworthy ETF Inflows: IWD, JPM, XOM, JNJ.NEWS13: Where Does Apple Rank in the Wearables Market?.NEWS14: Can You Hide in Johnson and Johnson Stock Amid the Turmoil?.NEWS15: Dow Movers: BA, VZ.NEWS16: Dow Movers: BA, VZ.NEWS17: AbbVie Halts Rova-T Phase III Second-Line Lung Cancer Study.NEWS18: Health Care Sector Update for 12/06/2018: APHA, CGC, RSLS, JNJ, PFE, MRK, ABT, AMGN.NEWS19: Health Care Sector Update for 12/06/2018: APHA, CGC, RSLS, JNJ, PFE, MRK, ABT, AMGN.NEWS20: [$$] Actelion Pharmaceuticals agrees to pay $360m in DoJ settlement.
2018-12-07: NEWS1: Stocks Swallow Steep Weekly Losses; Oil, Gold End Higher.NEWS2: Stocks Swallow Steep Weekly Losses; Oil, Gold End Higher.NEWS3: Market Close Report: NASDAQ Composite index closes at 6,969.25 down -219.01 points.NEWS4: Market Close Report: NASDAQ Composite index closes at 6,969.25 down -219.01 points.NEWS5: Health Care Sector Update for 12/07/2018: GBT, VIVE, CRON, MO, JNJ, PFE, MRK, ABT, AMGN.NEWS6: Health Care Sector Update for 12/07/2018: GBT, VIVE, CRON, MO, JNJ, PFE, MRK, ABT, AMGN.NEWS7: Why Johnson & Johnson is a Top 25 Dividend Giant (JNJ).NEWS8: Why Johnson & Johnson is a Top 25 Dividend Giant (JNJ).NEWS9: Health Care Sector Update for 12/07/2018: CRON, VIVE, MO, FMS, JNJ, PFE, MRK, ABT, AMGN.NEWS10: Health Care Sector Update for 12/07/2018: CRON, VIVE, MO, FMS, JNJ, PFE, MRK, ABT, AMGN.NEWS11: PRESS DIGEST-New York Times business news - Dec 7.NEWS12: 7 Dividend Titans Trading Like Growth Stocks.NEWS13: 7 Dividend Titans Trading Like Growth Stocks.NEWS14: Johnson & Johnson (JNJ) Stock Moves -0.08%: What You Should Know.NEWS15: Johnson & Johnson (JNJ) Stock Moves -0.08%: What You Should Know.
2018-12-10: NEWS1: How Endo International’s Gross Margin Has Trended.NEWS2: PFE Stock Has Broken Its Slump and Could Challenge Former Highs.NEWS3: PFE Stock Has Broken Its Slump and Could Challenge Former Highs.NEWS4: The Zacks Analyst Blog Highlights: Apple, DowDuPont, Exxon Mobil, Johnson & Johnson and Verizon Communications.NEWS5: The Zacks Analyst Blog Highlights: Apple, DowDuPont, Exxon Mobil, Johnson & Johnson and Verizon Communications.NEWS6: The Zacks Analyst Blog Highlights: Apple, DowDuPont, Exxon Mobil, Johnson & Johnson and Verizon Communications.NEWS7: PFE Stock Has Broken Its Slump and Could Challenge Former Highs.NEWS8: Health Care Sector Update for 12/10/2018: AXON, MRNS, RARX, JNJ, PFE, MRK, ABT, AMGN.NEWS9: Health Care Sector Update for 12/10/2018: AXON, MRNS, RARX, JNJ, PFE, MRK, ABT, AMGN.NEWS10: Today's Research Reports on Trending Tickers: Johnson & Johnson and Bristol-Myers Squibb.NEWS11: Is Johnson & Johnson (JNJ) A Good Stock According To Hedge Funds?.NEWS12: Stock Market Power Rankings: Amazon Takes Control.NEWS13: Stock Market Power Rankings: Amazon Takes Control.
2018-12-11: NEWS1: Cramer: Pick individual stocks with long-term growth stories in this 'treacherous' market.NEWS2: Why Is Shopify Stock Holding Up While Others Can’t Handle The Turmoil?.NEWS3: Why Is Shopify Stock Holding Up While Others Can’t Handle The Turmoil?.NEWS4: Markets Right Now: Stock market ends mixed after a bumpy day.NEWS5: Will Wayfair Stock Remain a Safety Play During Market Turbulence?.NEWS6: Will Wayfair Stock Remain a Safety Play During Market Turbulence?.NEWS7: MYOS Muscling Up, CORT Turns Heads, Former FDA Official Joins PTE Board.NEWS8: MYOS Muscling Up, CORT Turns Heads, Former FDA Official Joins PTE Board.NEWS9: Today's Stock Market: Dow Jones Volatile After Trump Spars With Democratic Leaders.NEWS10: Understanding Regeneron Pharmaceuticals’ Operational Performance.NEWS11: Regeneron Pharmaceuticals’ Gross Margin Trends.NEWS12: What Are Tesaro’s Revenue Projections for Fiscal 2018?.NEWS13: Why Is Shopify Stock Holding Up While Others Can’t Handle The Turmoil?.NEWS14: Bristol-Myers to Study Opdivo in Combo With Vedanta's VE800.NEWS15: Bristol-Myers to Study Opdivo in Combo With Vedanta's VE800.NEWS16: Will Wayfair Stock Remain a Safety Play During Market Turbulence?.NEWS17: Bristol-Myers to Study Opdivo in Combo With Vedanta's VE800.NEWS18: Health Care Sector Update for 12/11/2018: ENTX, AMGN, ITCI, NVS, JNJ, PFE, MRK, ABT.NEWS19: Health Care Sector Update for 12/11/2018: ENTX, AMGN, ITCI, NVS, JNJ, PFE, MRK, ABT.NEWS20: How Much Upside Do Analysts Expect in Endo Stock?.NEWS21: See what the IHS Markit Score report has to say about Johnson & Johnson..NEWS22: Pennovation Center-based biotech startup raises $13M.NEWS23: What Endo International’s Bottom Line Trend Indicates.
2018-12-12: NEWS1: Why Arrowhead Pharmaceuticals Surged 11% Higher Today.NEWS2: Why Arrowhead Pharmaceuticals Surged 11% Higher Today.NEWS3: Johnson & Johnson (JNJ) Gains But Lags Market: What You Should Know.NEWS4: Why Arrowhead Pharmaceuticals Surged 11% Higher Today.NEWS5: J&J Reportedly Willing To Pay $400 Million-Plus In Hip-Device Cases.NEWS6: J&J Reportedly Willing To Pay $400 Million-Plus In Hip-Device Cases.NEWS7: J&J says its psoriasis drug superior to Novartis treatment in study.NEWS8: 5 Pharma Stocks That Could Cure Ailing Portfolios in 2019.NEWS9: 5 Pharma Stocks That Could Cure Ailing Portfolios in 2019.NEWS10: Health Care Sector Update for 12/12/2018: XBIT, SGYP, NBIX, MRNS, JNJ, PFE, MRK, ABT, AMGN.NEWS11: Health Care Sector Update for 12/12/2018: XBIT, SGYP, NBIX, MRNS, JNJ, PFE, MRK, ABT, AMGN.NEWS12: Portola (PTLA) Down as CHMP Defers Review Date for Ondexxya.NEWS13: Portola (PTLA) Down as CHMP Defers Review Date for Ondexxya.NEWS14: 5 Pharma Stocks That Could Cure Ailing Portfolios in 2019.NEWS15: Here's How to Survive a Stock Market Crash.NEWS16: Here's How to Survive a Stock Market Crash.NEWS17: Portola (PTLA) Down as CHMP Defers Review Date for Ondexxya.NEWS18: Health Care Sector Update for 12/12/2018: SGYP, NBIX, MRNS, JNJ, PFE, MRK, ABT, AMGN.NEWS19: Health Care Sector Update for 12/12/2018: SGYP, NBIX, MRNS, JNJ, PFE, MRK, ABT, AMGN.NEWS20: Do Analysts See Any Upside for Regeneron Stock?.NEWS21: Here&apos;s How to Survive a Stock Market Crash.NEWS22: What Regeneron Pharmaceuticals’ Bottom Line Indicates.NEWS23: J&J says its psoriasis drug superior to Novartis' in study.NEWS24: Arrowhead Pharmaceuticals (ARWR) Q4 2018 Earnings Conference Call Transcript.

Answer: Rise